New Drug Approved for All Cancers With Genetic Marker

TUESDAY, May 23, 2017 -- Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat any cancer that has a certain genetic biomarker, regardless of where in the body the cancer originated. " This is an important...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news